Funder: INDUSTRIAL FARMACEUTICA CANTABRIA S.A.
edit_calendar Duration: from 20 January 2023 to 20 January 2025 (24 months) Current

Of National scope. It has been granted under a regime of Direct grant.

Call: (INDUSTRIAL FARMACEUTICA CANTABRIA S.A.)

Researchers